3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
6
Prostatic Neoplasms
3
Neoplasms
3
Motor Activity
3
Pancreatic Neoplasms
2
Overweight
2
Obesity
2
Malnutrition
2
Lung Neoplasms
2
Colorectal Neoplasms
2
Weight Loss
1
Urinary Bladder Neoplasms
1
Taste Disorders
1
Stomach Neoplasms
1
Small Cell Lung Carcinoma
1
Sarcopenia
1
Rectal Neoplasms
1
Patient Compliance
1
Ovarian Neoplasms
1
Obesity-Related Malignant Neoplasm
1
Neoplasms, Plasma Cell
1
Neoplasm Metastasis
1
Metabolic Diseases
1
Lymphoma
1
Locally Advanced Head and Neck Squamous Cell Carcinoma
1
Hypertension
1
Hypercholesterolemia
1
Heart Failure
1
Heart Diseases
1
Esophageal Neoplasms
1
Interventions
pembrolizumab
96
Carboplatin
67
Paclitaxel
56
Cyclophosphamide
40
Capecitabine
30
Specimen Handling
28
sacituzumab govitecan
25
130-nm albumin-bound paclitaxel
24
Gemcitabine
22
Magnetic Resonance Spectroscopy
21
Doxorubicin
20
olaparib
19
Taxes
19
Biopsy
19
Albumin-Bound Paclitaxel
19
Drug Therapy
16
atezolizumab
13
Nivolumab
13
toripalimab
12
Radiotherapy
12
Epirubicin
12
durvalumab
11
Docetaxel
10
Cisplatin
10
Bevacizumab
10
eribulin
9
fludarabine
8
Standard of Care
7
Radiation
7
Injections
7
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Triple Negative Breast Neoplasms
×
Nutrition Assessment
×
1 year
×
Clear all
No trials found.